Emcure Pharmaceuticals Limited (EMCURE)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 970.29 1,104.63 1,028.81 1,278.19 1,096.57 1,260.60 1,418.31 1,467.70
YOY Revenue Growth % - - - - 13.01% 14.12% 37.86% 14.83%
Other Income 32.51 54.93 19.41 22.40 21.52 22.75 138.30 26.94
Total Income 1,002.80 1,159.56 1,048.22 1,300.58 1,118.10 1,283.36 1,556.61 1,494.64
Total Expenses + 705.07 773.66 776.78 1,114.53 948.93 1,125.47 1,213.09 1,195.96
Cost of Materials Consumed 266.07 325.99 350.91 365.01 354.63 374.18 368.53 377.85
Employee Benefit Expense 195.09 191.12 196.01 198.16 210.42 202.68 205.65 202.37
Other Expenses 243.91 256.56 229.86 227.41 249.97 266.76 296.77 245.00
Operating Profit 265.23 330.97 252.03 163.66 147.65 135.14 205.22 271.75
OPM % 27.3% 30% 24.5% 12.8% 13.5% 10.7% 14.5% 18.5%
Profit Before Tax + 55.05 119.36 67.25 186.05 165.67 157.89 314.37 306.27
Tax Expense 14.60 32.44 17.05 46.50 42.88 40.27 55.51 72.57
Tax % 26.5% 27.2% 25.3% 25% 25.9% 25.5% 17.7% 23.7%
Profit After Tax 40.45 86.92 50.20 139.56 122.79 117.62 258.85 233.70
EPS (Basic) 2.23 4.62 2.65 7.37 6.48 6.21 13.65 12.33

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 4,381.92
YOY Revenue Growth % -
Other Income 118.81
Total Income 4,500.73
Total Expenses + 4,073.02
Cost of Materials Consumed 1,307.98
Employee Benefit Expense 782.31
Other Expenses 945.37
Operating Profit 308.90
OPM % 7%
Profit Before Exceptional 427.71
Exceptional Items 0.00
Profit Before Tax + 427.71
Tax Expense 110.58
Tax % 25.9%
Profit After Tax 317.13
EPS (Basic) 16.95

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 2,908.86
Property, Plant & Equipment 1,459.85
Capital Work in Progress 92.83
Non-Current Investments 677.65
Goodwill 0.00
Other Intangible Assets 26.22
Current Assets + 2,507.25
Inventories 1,038.18
Trade Receivables 1,190.56
Cash and Cash Equivalents 8.49
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 189.48
Other Equity 2,834.88
Non-Current Liabilities 672.59
Current Liabilities 1,719.16
Total Liabilities 2,391.75

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 558.29
Cash from Investing Activities -435.61
Cash from Financing Activities -49.25
Net Increase/Decrease in Cash 71.38